These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 26786644)

  • 1. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.
    Mah JK; Korngut L; Fiest KM; Dykeman J; Day LJ; Pringsheim T; Jette N
    Can J Neurol Sci; 2016 Jan; 43(1):163-77. PubMed ID: 26786644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.
    Mah JK; Korngut L; Dykeman J; Day L; Pringsheim T; Jette N
    Neuromuscul Disord; 2014 Jun; 24(6):482-91. PubMed ID: 24780148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hospital based epidemiological study of genetically determined muscle disease in south western Norway.
    Husebye SA; Rebne CB; Stokland AE; Sanaker PS; Bindoff LA
    Neuromuscul Disord; 2020 Mar; 30(3):181-185. PubMed ID: 32146000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of muscular dystrophies: a systematic literature review.
    Theadom A; Rodrigues M; Roxburgh R; Balalla S; Higgins C; Bhattacharjee R; Jones K; Krishnamurthi R; Feigin V
    Neuroepidemiology; 2014; 43(3-4):259-68. PubMed ID: 25532075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular Dystrophies.
    Carter JC; Sheehan DW; Prochoroff A; Birnkrant DJ
    Clin Chest Med; 2018 Jun; 39(2):377-389. PubMed ID: 29779596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The muscular dystrophies.
    Flanigan KM
    Semin Neurol; 2012 Jul; 32(3):255-63. PubMed ID: 23117950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary muscular dystrophies and the heart.
    Hermans MC; Pinto YM; Merkies IS; de Die-Smulders CE; Crijns HJ; Faber CG
    Neuromuscul Disord; 2010 Aug; 20(8):479-92. PubMed ID: 20627570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.
    Spitali P; Hettne K; Tsonaka R; Sabir E; Seyer A; Hemerik JBA; Goeman JJ; Picillo E; Ergoli M; Politano L; Aartsma-Rus A
    J Cell Mol Med; 2018 Apr; 22(4):2442-2448. PubMed ID: 29441734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.
    Do TN; Street N; Donnelly J; Adams MM; Cunniff C; Fox DJ; Weinert RO; Oleszek J; Romitti PA; Westfield CP; Bolen J;
    Birth Defects Res; 2018 Nov; 110(19):1404-1411. PubMed ID: 30070776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The muscular dystrophies.
    Wicklund MP
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1535-70. PubMed ID: 24305447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets to treat muscular dystrophies.
    Kinter J; Sinnreich M
    Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of congenital myopathies and muscular dystrophies.
    Massalska D; Zimowski JG; Bijok J; Kucińska-Chahwan A; Łusakowska A; Jakiel G; Roszkowski T
    Clin Genet; 2016 Sep; 90(3):199-210. PubMed ID: 27197572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates.
    Winblad S; Jensen C; Månsson JE; Samuelsson L; Lindberg C
    Behav Brain Funct; 2010 May; 6():25. PubMed ID: 20482818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis.
    Leone E; Pandyan A; Rogers A; Kulshrestha R; Hill J; Philp F
    J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):442-453. PubMed ID: 38124127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
    Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
    Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and morphometrical study of the muscle spindle in muscular dystrophy.
    Kararizou EG; Manta P; Kalfakis N; Gkiatas KA; Vassilopoulos D
    Anal Quant Cytol Histol; 2007 Jun; 29(3):148-52. PubMed ID: 17672374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques.
    Nakagawa M; Nakahara K; Yoshidome H; Suehara M; Higuchi I; Fujiyama J; Nakamura A; Kubota R; Takenaga S; Arahata K
    Neuroepidemiology; 1991; 10(4):185-91. PubMed ID: 1745328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of risk factors associated with muscular dystrophies.
    Barakat-Haddad C; Shin S; Candundo H; Lieshout PV; Martino R
    Neurotoxicology; 2017 Jul; 61():55-62. PubMed ID: 27018093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.